Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass

Surgery Today

Volumn 41, Issue 10, 2011, Pages 1385-1390

  Hasegawa, Akira ^a   Iwasaka, Hideo ^a   Hagiwara, Satoshi ^a   Koga, Hironori ^a   Hasegawa, Rie ^a   Kudo, Kyosuke ^a   Kusaka, Junya ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cardiovascular surgery; Cytokine; General anesthesia; Infl ammation; Intensive insulin therapy

Indexed keywords

GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; INTENSIVE CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL;

AGED; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; CARDIOPULMONARY BYPASS; HMGB1 PROTEIN; HUMANS; HYPOGLYCEMIA; INFLAMMATION; INSULIN; INSULIN INFUSION SYSTEMS; INTERLEUKIN-6; MIDDLE AGED; PANCREAS, ARTIFICIAL; PERIOPERATIVE CARE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80855140832     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4458-y     Document Type: Article

References (18)

1. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006;141:1132-40. (Pubitemid 44790546)
2. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996;20:454-9. (Pubitemid 26138593)
3. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
4. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T. Hyperglycemia contributes to cardiac dysfunction in a lipopolysaccharide- induced systemic inflammation model. Crit Care Med 2009;37:2223-7.
5. Hagiwara S, Iwasaka H, Hasegawa A, Koga H, Noguchi T. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med 2008;36:2407-13.
6. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
7. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-44.
8. Yamashita K, Yatabe T. Intraoperative glycemic control procedures and the use of an artificial pancreas. World J Gastroenterol 2009;15:4126-31.
9. Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008;26:711-5. (Pubitemid 351905818)
10. Karlsson S, Pettilä V, Tenhunen J, Laru-Sompa R, Hynninen M, Ruokonen E. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 2008;34:1046-53. (Pubitemid 351903793)
11. Kyle UG, Coss Bu JA, Kennedy CE, Jefferson LS. Organ dysfunction is associated with hyperglycemia in critically ill children. Intensive Care Med 2010;36:312-20.
12. van Kuijk JP, Schouten O, Flu WJ, den Uil CA, Bax JJ, Poldermans D. Perioperative blood glucose monitoring and control in major vascular surgery patients. Eur J Vasc Endovasc Surg 2009;38: 627-34.
13. Kawahito S, Kitahata H, Kitagawa T, Oshita S. Intensive insulin therapy during cardiovascular surgery. J Med Invest 2010;57: 191-204.
14. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, et al. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial. Arch Surg 2009;144:933-7.
15. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closedloop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 2009;32:1425-7.
16. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, et al. Increased plasma levels of IL-6 and IL-8 are associated with surgical site infection after pancreaticoduodenectomy. Pancreas 2006;32:178-85.
17. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008;106:160-3.
18. Hanazaki K, Maeda H, Okabayashi T. Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010;40:1-7.